Literature DB >> 30232279

Neutrophil accumulation and NET release contribute to thrombosis in HIT.

Kandace Gollomp1,2, Minna Kim1, Ian Johnston3, Vincent Hayes4, John Welsh5, Gowthami M Arepally6, Mark Kahn5, Michele P Lambert1,2, Adam Cuker4,5, Douglas B Cines4,5, Lubica Rauova1,2, M Anna Kowalska1,7, Mortimer Poncz1,2.   

Abstract

Heparin-induced thrombocytopenia (HIT) is an immune-mediated thrombocytopenic disorder associated with a severe prothrombotic state. We investigated whether neutrophils and neutrophil extracellular traps (NETs) contribute to the development of thrombosis in HIT. Using an endothelialized microfluidic system and a murine passive immunization model, we show that HIT induction leads to increased neutrophil adherence to venous endothelium. In HIT mice, endothelial adherence is enhanced immediately downstream of nascent venous thrombi, after which neutrophils undergo retrograde migration via a CXCR2-dependent mechanism to accumulate into the thrombi. Using a microfluidic system, we found that PF4 binds to NETs, leading them to become compact and DNase resistant. PF4-NET complexes selectively bind HIT antibodies, which further protect them from nuclease digestion. In HIT mice, inhibition of NET formation through Padi4 gene disruption or DNase treatment limited venous thrombus size. PAD4 inactivation did affect arterial thrombi or severity of thrombocytopenia in HIT. Thus, neutrophil activation contributes to the development of venous thrombosis in HIT by enhancing neutrophil-endothelial adhesion and neutrophil clot infiltration, where incorporated PF4-NET-HIT antibody complexes lead to thrombosis propagation. Inhibition of neutrophil endothelial adhesion, prevention of neutrophil chemokine-dependent recruitment of neutrophils to thrombi, or suppression of NET release should be explored as strategies to prevent venous thrombosis in HIT.

Entities:  

Keywords:  Autoimmune diseases; Hematology; Inflammation; Neutrophils; Thrombosis

Mesh:

Substances:

Year:  2018        PMID: 30232279      PMCID: PMC6237233          DOI: 10.1172/jci.insight.99445

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  60 in total

1.  Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?

Authors:  Amy Zhou; Anne Winkler; Amir Emamifar; Bryce Gartland; Alexander Duncan; Ana Antun; Martha Arellano; G Allen Tindol; Jerrold H Levy; William A Bornstein; Ira R Horowitz; Hanna Jean Khoury
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

2.  Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.

Authors:  G M Arepally; S Kamei; K S Park; K Kamei; Z Q Li; W Liu; D L Siegel; W Kisiel; D B Cines; M Poncz
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

3.  Neutrophil extracellular traps promote deep vein thrombosis in mice.

Authors:  A Brill; T A Fuchs; A S Savchenko; G M Thomas; K Martinod; S F De Meyer; A A Bhandari; Denisa D Wagner
Journal:  J Thromb Haemost       Date:  2012-01       Impact factor: 5.824

4.  Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury.

Authors:  Axelle Caudrillier; Kai Kessenbrock; Brian M Gilliss; John X Nguyen; Marisa B Marques; Marc Monestier; Pearl Toy; Zena Werb; Mark R Looney
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

Review 5.  Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

6.  Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria.

Authors:  Sven Brandt; Krystin Krauel; Miriam Jaax; Thomas Renné; Christiane A Helm; Sven Hammerschmidt; Mihaela Delcea; Andreas Greinacher
Journal:  Thromb Haemost       Date:  2015-07-30       Impact factor: 5.249

7.  Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition.

Authors:  John G Kelton; Marcie J Hursting; Nancy Heddle; Bruce E Lewis
Journal:  Blood Coagul Fibrinolysis       Date:  2008-09       Impact factor: 1.276

8.  Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion.

Authors:  Zhihua Xiao; Gian P Visentin; Kannayakanahalli M Dayananda; Sriram Neelamegham
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

9.  SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects.

Authors:  O Holz; S Khalilieh; A Ludwig-Sengpiel; H Watz; P Stryszak; P Soni; M Tsai; J Sadeh; H Magnussen
Journal:  Eur Respir J       Date:  2009-07-30       Impact factor: 16.671

10.  Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.

Authors:  Huw D Lewis; John Liddle; Jim E Coote; Stephen J Atkinson; Michael D Barker; Benjamin D Bax; Kevin L Bicker; Ryan P Bingham; Matthew Campbell; Yu Hua Chen; Chun-Wa Chung; Peter D Craggs; Rob P Davis; Dirk Eberhard; Gerard Joberty; Kenneth E Lind; Kelly Locke; Claire Maller; Kimberly Martinod; Chris Patten; Oxana Polyakova; Cecil E Rise; Martin Rüdiger; Robert J Sheppard; Daniel J Slade; Pamela Thomas; Jim Thorpe; Gang Yao; Gerard Drewes; Denisa D Wagner; Paul R Thompson; Rab K Prinjha; David M Wilson
Journal:  Nat Chem Biol       Date:  2015-01-26       Impact factor: 15.040

View more
  52 in total

1.  The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics.

Authors:  Xiaoyu Zhang; Rongxia Guo; Hiroto Kambara; Fengxia Ma; Hongbo R Luo
Journal:  Curr Opin Hematol       Date:  2019-01       Impact factor: 3.284

2.  Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

Authors:  Luise Goldmann; Rundan Duan; Thorsten Kragh; Georg Wittmann; Christian Weber; Reinhard Lorenz; Philipp von Hundelshausen; Michael Spannagl; Wolfgang Siess
Journal:  Blood Adv       Date:  2019-12-10

Review 3.  Extracellular DNA NET-Works With Dire Consequences for Health.

Authors:  Nicoletta Sorvillo; Deya Cherpokova; Kimberly Martinod; Denisa D Wagner
Journal:  Circ Res       Date:  2019-08-01       Impact factor: 17.367

4.  Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension.

Authors:  Moira B Hilscher; Tejasav Sehrawat; Juan P Arab; Zhutian Zeng; Jinhang Gao; Mengfei Liu; Enis Kostallari; Yandong Gao; Douglas A Simonetto; Usman Yaqoob; Sheng Cao; Alexander Revzin; Arthur Beyder; Rong A Wang; Patrick S Kamath; Paul Kubes; Vijay H Shah
Journal:  Gastroenterology       Date:  2019-03-11       Impact factor: 22.682

5.  Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia.

Authors:  Kristin M Hudock; Margaret S Collins; Michelle Imbrogno; John Snowball; Elizabeth L Kramer; John J Brewington; Kandace Gollomp; Cormac McCarthy; Alicia J Ostmann; Elizabeth J Kopras; Cynthia R Davidson; Anusha Srdiharan; Paritha Arumugam; Shaon Sengupta; Yan Xu; G Scott Worthen; Bruce C Trapnell; John Paul Clancy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-11       Impact factor: 5.464

6.  Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura.

Authors:  Jingrui Sui; Ruinan Lu; Konstantine Halkidis; Nicole K Kocher; Wenjing Cao; Marisa B Marques; X Long Zheng
Journal:  J Thromb Haemost       Date:  2021-01-03       Impact factor: 5.824

7.  Increased Incidence of Venous Thromboembolism with Cancer Immunotherapy.

Authors:  Joanna Roopkumar; Shadi Swaidani; Ann S Kim; Bicky Thapa; Lorenzo Gervaso; Brian P Hobbs; Wei Wei; Tyler J Alban; Pauline Funchain; Suman Kundu; Naseer Sangwan; Patricia Rayman; Paul G Pavicic; C Marcela Diaz-Montero; John Barnard; Keith R McCrae; Alok A Khorana
Journal:  Med (N Y)       Date:  2021-03-12

Review 8.  Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.

Authors:  Gowthami M Arepally; Anand Padmanabhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

9.  Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes.

Authors:  Sanjay Khandelwal; Ayiesha Barnes; Lubica Rauova; Amrita Sarkar; Ann H Rux; Serge V Yarovoi; S Sergei Zaitsev; John D Lambris; Sooho S Myoung; Alexandra Johnson; Grace M Lee; Madelaine Duarte; Mortimer Poncz; Gowthami M Arepally; Douglas B Cines
Journal:  Blood       Date:  2021-11-25       Impact factor: 22.113

Review 10.  Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.

Authors:  Jon Hazeldine; Janet M Lord
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.